Pharmacokinetic Variability of Long-Acting Stimulants in the Treatment of Children and Adults with Attention-Deficit Hyperactivity Disorder

By Ermer James C.  

CNS Drugs, Vol. 24, Iss. 12, 2010-12 ,pp. : 1009-1025

Adis International

Access to resources Recommend Favorite

Lisdexamfetamine is a promising treatment for children with attention-deficit hyperactivity disorder

By  

Inpharma, Vol. 1, Iss. 1543, 2006-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Role of Zinc in the Pathogenesis of Attention-Deficit Hyperactivity Disorder: Implications for Research and Treatment

By Lepping Peter  

CNS Drugs, Vol. 24, Iss. 9, 2010-09 ,pp. : 721-728

Adis International

Access to resources Recommend Favorite

Limited data suggest that the long-term use of stimulants in children with attention-deficit hyperactivity disorder is effective and safe

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 20, Iss. 11, 2004-11 ,pp. : 14-16

Adis International

Access to resources Recommend Favorite

Compliance with Stimulants for Attention-Deficit/ Hyperactivity Disorder: Issues and Approaches for Improvement

By Swanson J.  

CNS Drugs, Vol. 17, Iss. 2, 2003-01 ,pp. : 117-131

Adis International

Access to resources Recommend Favorite